SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
Vertex receives FDA approval for one of our CF medicines in children with cystic fibrosis ages 12 to <24 months
Our investigational pain medicine advances into pivotal development for acute pain and receives U.S. FDA Breakthrough Therapy Designation
Vertex announces that the U.S. FDA has lifted the clinical hold on the Phase 1/2 clinical trial for the potential treatment of type 1 diabetes
Vertex and CRISPR Tx present new data at EHA 2022 on investigational gene-edited therapy for the treatment of sickle cell...
Our investigational medicine for the potential treatment of APOL1-mediated kidney disease receives two regulatory designations
Working at Vertex
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Featured Stories
This September, join us in recognizing Duchenne Action Month by learning from some of our female scientists working on Duchenne muscular dystrophy (DMD). These scientists are passionate about their research and raising awareness for DMD.
The Sickle Cell Disease Partnership is a multistakeholder coalition, launched in June, which works to improve care and access for people living with sickle cell disease. Here, Chief Patient Officer Amit Sachdev discusses the partnership, its goals and the reasons it was founded.
Vertex is proud to share that it has been named — once again — to Seramount’s 100 Best Companies list and the Best Companies for Dads list. Learn more about what sets us apart and meet our Working Parents of the Year honorees, Genzy Davis and Ravin Warnakulasuriya.
This September, join us in recognizing Duchenne Action Month by learning from some of our female scientists working on Duchenne muscular dystrophy (DMD). These scientists are passionate about their research and raising awareness for DMD.
The Sickle Cell Disease Partnership is a multistakeholder coalition, launched in June, which works to improve care and access for people living with sickle cell disease. Here, Chief Patient Officer Amit Sachdev discusses the partnership, its goals and the reasons it was founded.
Vertex is proud to share that it has been named — once again — to Seramount’s 100 Best Companies list and the Best Companies for Dads list. Learn more about what sets us apart and meet our Working Parents of the Year honorees, Genzy Davis and Ravin Warnakulasuriya.
